<--- Back to Details
First PageDocument Content
Organic chemistry / Aspartame / Sugar substitute / Aspartame controversy / Saccharin / G. D. Searle & Company / Phenylalanine / Food and Drug Administration / Generally recognized as safe / Chemistry / Sweeteners / Food and drink
Date: 2005-08-09 18:18:49
Organic chemistry
Aspartame
Sugar substitute
Aspartame controversy
Saccharin
G. D. Searle & Company
Phenylalanine
Food and Drug Administration
Generally recognized as safe
Chemistry
Sweeteners
Food and drink

Untitled

Add to Reading List

Source URL: archive.gao.gov

Download Document from Source Website

File Size: 1,01 MB

Share Document on Facebook

Similar Documents

Copyright / Data management / Library science / Metadata / Monopoly / Microcontroller / Booting / EEPROM / G. D. Searle & Company / Computer hardware / Data / Information

Breaking  and  Fixing   Cri.cal  Infrastructure   Jus.n  Searle   Managing  Partner  –  U.liSec      //    @meeas  

DocID: 18W1q - View Document

Food and drink / Dipeptides / Aspartame / Propionates / Food and Drug Administration / G. D. Searle & Company / Russell Blaylock / Aspartame controversy / NutraSweet / Chemistry / Sweeteners / Organic chemistry

The FDA who not only revoked the petition for approval of aspartame but tried to have the original manufacturer, Searle, indicted today along with the professional organizations funded by the manufacturers and the front

DocID: 12SGC - View Document

Sweeteners / Aspartame / Dipeptides / Propionates / G. D. Searle & Company / Sugar substitute / Clinical research / Food and Drug Administration / Chemistry / Health / Organic chemistry

The "Bressler Report" (Mammary tumor “Adenocarcinoma” found in 1972 animal study pp6,67,70) (Note: This is the text of an FDA report on Searle) EIR[removed]to[removed]JSA/DME/JT/LF

DocID: QCRi - View Document

Organic chemistry / Dipeptides / Aspartame / Propionates / Aspartame controversy / NutraSweet / European Food Safety Authority / G. D. Searle & Company / Monsanto / Sweeteners / Chemistry / Food and drink

Prof Erik Millstone SPRU- Science and Technology Policy Research Freeman Centre, Jubilee Building University of Sussex Brighton BN1 9SL 22 February 2013

DocID: OoM2 - View Document

Arthritis / Connective tissue diseases / COX-2 inhibitors / Sulfonamides / Celecoxib / G. D. Searle & Company / Rheumatoid arthritis / Juvenile idiopathic arthritis / Non-steroidal anti-inflammatory drug / Health / Medicine / Pfizer

Disclosure Document for an 18 U

DocID: ECjt - View Document